Objective. Students will explain the clinical indications, physiological mechanism, and patient monitoring requirements for pressure support ventilation, CPAP, APRV, and non-invasive positive pressure ventilation, and correctly configure each mode on a training ventilator.
This lesson, its worked examples and its practice questions has not yet been verified by a licensed clinician in the field or by a certification or approval body. It is a study draft and may contain errors. Do not use it to make decisions about any patient or medication. Always follow your instructor, your supervising professional, and current official references and regulations.
VoTechWorks program approval and accreditation are still in progress. Credentials are issued only by the certifying bodies named in each program, after their own exams.
Understanding advanced ventilator modes is essential for any respiratory therapist. Each mode targets a specific physiological problem, and choosing the wrong one can harm a patient. This lesson covers the clinical indications, mechanisms, and monitoring requirements for pressure support ventilation (PSV), continuous positive airway pressure (CPAP), airway pressure release ventilation (APRV), and non-invasive positive pressure ventilation (NPPV).
Pressure support is a patient-triggered, pressure-limited, flow-cycled mode. Every breath is initiated by the patient; the ventilator detects the inspiratory effort and delivers a set pressure boost above the baseline (PEEP) until inspiratory flow drops to a threshold — typically a percentage of peak flow — at which point the machine cycles off.
How it works: When the patient inhales, airway pressure briefly drops. The ventilator senses this trigger and pressurizes the circuit to the set support level. This reduces the work the patient's respiratory muscles must perform to move each tidal volume. The resulting tidal volume depends on the patient's lung compliance, resistance, and effort — PSV does not guarantee a fixed tidal volume.
Clinical indications: PSV is used during weaning from mechanical ventilation, as a comfort mode during synchronized intermittent mandatory ventilation (SIMV), and as a stand-alone mode in spontaneously breathing patients with adequate respiratory drive.
Monitoring: Watch tidal volume closely. If lung mechanics worsen (e.g., bronchospasm, secretion retention), tidal volume will fall even at the same support level. Monitor respiratory rate; a rising rate may signal fatigue or inadequate support. Loss of patient effort will cause apnea — ensure a backup rate or apnea alarm is active.
Safety point: PSV is contraindicated as a sole mode in patients with unreliable or absent respiratory drive. Always confirm apnea alarm settings before leaving the bedside.
CPAP delivers a constant elevated baseline pressure throughout both inspiration and expiration without providing any additional inspiratory pressure boost. The patient breathes spontaneously against this elevated baseline.
Physiological effect: The elevated pressure splints open the upper airway and recruits collapsed alveoli, improving functional residual capacity (FRC) and oxygenation. It reduces the work of breathing in conditions where airway collapse is the primary problem.
Clinical indications: Obstructive sleep apnea, cardiogenic pulmonary edema (with caution), post-extubation support, and facilitating weaning trials (spontaneous breathing trials at low CPAP levels).
Monitoring: Monitor SpO₂, respiratory rate, work of breathing signs (accessory muscle use, nasal flaring), and patient comfort. Ensure the mask or interface fits without excessive leak.
Safety point: CPAP provides no backup breaths. If the patient's drive fails, there is no ventilatory support. Apnea alarm must be active and response protocols in place.
APRV is a time-cycled mode that maintains a high continuous airway pressure (P-High) for a prolonged time (T-High), then releases to a lower pressure (P-Low) for a very brief release phase (T-Low) before returning to P-High.
How it works: The extended P-High phase recruits and maintains open alveoli — this is especially valuable in diffuse alveolar injury (ARDS). The brief release phase allows CO₂ elimination. Spontaneous breathing is encouraged throughout the cycle, which improves patient-ventilator synchrony and reduces sedation requirements compared to conventional high-PEEP strategies.
Clinical indications: Moderate-to-severe ARDS, refractory hypoxemia. APRV is typically initiated and managed by experienced practitioners; as a new RT, you will assist and monitor rather than initiate independently.
Monitoring: Closely watch mean airway pressure, SpO₂, and exhaled tidal volumes during the release phase. T-Low is intentionally kept short — usually ending when expiratory flow has not fully returned to baseline — to prevent alveolar de-recruitment. Confirm settings with a physician or senior RT before adjustment.
Safety point: Incorrect T-Low settings can cause auto-PEEP or inadequate CO₂ clearance. Document and report any changes in patient–ventilator synchrony immediately.
NPPV delivers positive pressure ventilation via a mask or nasal interface, avoiding endotracheal intubation. The most common NPPV mode is BiPAP (bilevel positive airway pressure), which delivers a higher inspiratory positive airway pressure (IPAP) and a lower expiratory positive airway pressure (EPAP).
How it works: IPAP augments inspiratory effort (like PSV); EPAP maintains airway patency and alveolar recruitment (like PEEP/CPAP). The difference between IPAP and EPAP (pressure support level) drives tidal volume.
Clinical indications: Acute hypercapnic respiratory failure (e.g., COPD exacerbation), cardiogenic pulmonary edema, immunocompromised patients who need ventilatory support without intubation, and sleep apnea management.
Mask fit is critical. A poorly fitted mask causes excessive leak, reduced tidal volumes, skin breakdown, and patient intolerance. Size the mask correctly: it should cover nose and mouth without resting on the eyes or chin. After application, observe the waveform on the ventilator — a leak-compensated waveform that stabilizes confirms adequate seal.
Contraindications: Inability to protect the airway, copious secretions, facial trauma, hemodynamic instability, and patient refusal.
Monitoring: Watch tidal volumes on the test lung or patient monitor, respiratory rate, SpO₂, EtCO₂ if available, patient comfort, and mask interface for air leak and skin pressure injury.
Safety point: NPPV is not a substitute for intubation when the clinical condition is rapidly deteriorating. Reassess frequently — typically every 30 to 60 minutes after initiation — and be prepared to escalate to invasive ventilation promptly if the patient does not respond.
| Mode | Primary Use | Backup Breaths? | Key Risk |
|------|-------------|-----------------|----------|
| PSV | Weaning, reducing WOB | No | Apnea if drive fails |
| CPAP | Airway splinting, OSA | No | No ventilatory support |
| APRV | ARDS, refractory hypoxemia | Built-in via P-High | Auto-PEEP, complex titration |
| NPPV (BiPAP) | Hypercapnic failure, CHF | Optional backup rate | Mask leak, aspiration risk |
Always confirm mode settings with the supervising clinician before application to a patient. Document all settings, patient response, and any alarms in the medical record.
Answer each question, then check it. Nothing is recorded; this is your own practice.
A free tech program — complimentary, as our commitment to get America working. Help us build VoTechWorks. Tell us what works, what doesn’t, and what you want to learn.